Review of Operations Support for Research Changing Tomorrow Day held in fiscal 2013 Region Participants Volunteering  hours Number of  locations Number of  countries Japan 4,308 4,500 152 1 Americas 2,400 9,600 33 3 EMEA 713 4,296 34 21 Asia & Oceania 744 3,724 9 8 Total 8,165 22,120 228 33 Asia & Oceania Americas Japan EMEA Regional activities Support for the Advancement of Medicine Providing Training Opportunities for Research  Fellows from Developing Countries Through the Special Programme for Research and Training  in Tropical Diseases (TDR) of the World Health Organization  (WHO), Astellas accepted research fellows from developing  countries and provided them with job training related to  clinical development. In fiscal 2013, Astellas accepted one  trainee from Ethiopia at its clinical development division in  For details, please visit the following website. Astellas Foundation for Research on Metabolic  Disorders (Japanese only) http://www.astellas.com/jp/byoutai/ Astellas USA Foundation http://www.astellasusafoundation.org/ Besides its foundations, Astellas provides support to  research activities conducted by academic research institu- tions and other entities. This support is in line with national  guidelines for ensuring transparency with respect to col- laboration between pharmaceutical companies and  medical professionals. Astellas has established foundations in Japan, the U.S.,  Europe, Asia and Oceania. The main activities of these four  foundations are to provide financial assistance for research  and other support to foster advancement in medical science,  conduct philanthropic activities in local communities, and  contribute relief funds to assist with disaster recovery efforts.  Each foundation is operated according to the laws of the  respective regions where they are active. For example, in  Japan the Astellas Foundation for Research on Metabolic  Disorders provides grants for research in two areas: “highly  original and groundbreaking research initiatives” that help to  foster an understanding of diseases and develop innovative  treatment methods, and “research that promises highly  significant clinical results.” In fiscal 2013, the foundation  offered research grants totaling ¥104 million to 52 researchers  selected from among 593 applicants. In addition, the founda- tion provided a total of ¥20 million in financial aid to 10 individu- als studying abroad who were selected from 186 applicants. the U.S. and provided training on management skills related  to clinical trials and other related areas. For further information about Astellas activities regarding the society, please visit the following websites: Initiatives to Support Reconstruction of Areas Affected by the Great East Japan Earthquake http://www.astellas.com/jp/whats_new/effort/index.html (Japanese only) Donations of Ambulance http://www.astellas.com/en/csr/social/medical/ambulance.html Gifts of Wheelchair Vehicles http://www.astellas.com/en/csr/social/medical/gift.html Supporting United Nations Millennium Development Goals http://www.astellas.com/en/csr/social/medical/index.html Annual Report 2014 _  Astellas Pharma Inc.  65